DHI Stock Ownership Activity

DR HORTON INC 13F holders

3 value investing gurus have made changes to the DR HORTON INC (DHI) position according to the gurus' latest SEC quarterly report(s). The number of DHI shares has been increased by 2, decreased by 1 super investor(s).

Which gurus or hedge funds are buying DHI now?

According to the latest SEC filing(s) DR HORTON INC (DHI) has been bought by 2 gurus: Glenn Greenberg - Brave Warrior Advisors (added shares +5.57%) and Edgar Wachenheim III - Greenhaven Associates (added shares +1.13%).

To see more about who is investing in DR HORTON INC (DHI), please go to the DHI ownership page.

History
Name
Company
%
Activity
Share
Change
% change to
Portfolio
% of
Portfolio
2021 Q2 (3 results)
John Armitage
Egerton Capital
-18.86%
-1,935,851
-0.87%
3.74%
Edgar Wachenheim III
Greenhaven Associates
-27.98%
-227,631
-0.80%
1.55%
David Tepper
Appaloosa Management
-1.78%
-20,743
-0.04%
2.14%
Current price: $151.75 67.92% AVG reported price*: $90.37
2021 Q1 (3 results)
Edgar Wachenheim III
Greenhaven Associates
-67.51%
-2,238,596
-4.51%
2.17%
John Armitage
Egerton Capital
-2.83%
-298,776
-0.14%
4.82%
David Tepper
Appaloosa Management
buy
+786,375
+1.49%
1.01%
Current price: $151.75 70.28% AVG reported price*: $89.12
2020 Q4 (2 results)
Edgar Wachenheim III
Greenhaven Associates
-5.42%
-189,180
-0.25%
4.28%
John Armitage
Egerton Capital
+1.16%
+121,046
+0.05%
4.12%
Current price: $151.75 120.18% AVG reported price*: $68.92
2020 Q3 (3 results)
Edgar Wachenheim III
Greenhaven Associates
-55.99%
-2,810,004
-7.41%
3.67%
Glenn Greenberg
Brave Warrior Advisors
-100.00%
-1,324,702
-3.28%
0.00%
John Armitage
Egerton Capital
+11.84%
+1,105,627
+0.52%
4.88%
Current price: $151.75 100.65% AVG reported price*: $75.63
2020 Q2 (3 results)
Glenn Greenberg
Brave Warrior Advisors
-19.00%
-310,740
-0.86%
0.00%
Edgar Wachenheim III
Greenhaven Associates
-2.74%
-224,348
-0.28%
9.78%
John Armitage
Egerton Capital
+56.28%
+3,361,890
+1.38%
3.85%
Current price: $151.75 173.67% AVG reported price*: $55.45
2020 Q1 (3 results)
John Armitage
Egerton Capital
-38.42%
-2,813,407
-1.31%
1.59%
Edgar Wachenheim III
Greenhaven Associates
+0.95%
+77,031
+0.10%
10.36%
Glenn Greenberg
Brave Warrior Advisors
+42.97%
+491,536
+0.96%
3.20%
Current price: $151.75 346.32% AVG reported price*: $34.00
2019 Q4 (4 results)
Stephen Mandel
Lone Pine Capital
-100.00%
-1,833,596
-0.94%
0.00%
Edgar Wachenheim III
Greenhaven Associates
-2.83%
-236,721
-0.28%
9.55%
Glenn Greenberg
Brave Warrior Advisors
-9.37%
-86,288
-0.33%
2.33%
John Armitage
Egerton Capital
+3.50%
+301,377
+0.12%
3.37%
Current price: $151.75 187.68% AVG reported price*: $52.75
2019 Q3 (4 results)
Stephen Mandel
Lone Pine Capital
-73.18%
-5,003,130
-2.82%
0.00%
Edgar Wachenheim III
Greenhaven Associates
-1.77%
-100,613
-0.16%
5.96%
Glenn Greenberg
Brave Warrior Advisors
-0.39%
-4,977
-0.01%
3.55%
John Armitage
Egerton Capital
+4.33%
+388,643
+0.15%
3.54%
Current price: $151.75 187.90% AVG reported price*: $52.71
2019 Q2 (4 results)
Edgar Wachenheim III
Greenhaven Associates
-0.52%
-44,142
-0.03%
6.40%
Glenn Greenberg
Brave Warrior Advisors
-1.23%
-14,389
-0.04%
2.64%
Stephen Mandel
Lone Pine Capital
+89.26%
+5,862,601
+1.57%
3.33%
John Armitage
Egerton Capital
buy
+8,983,987
+2.84%
2.84%
Current price: $151.75 251.84% AVG reported price*: $43.13
2019 Q1 (3 results)
Edgar Wachenheim III
Greenhaven Associates
-0.85%
-66,771
-0.05%
5.72%
Glenn Greenberg
Brave Warrior Advisors
+12.29%
+140,439
+0.29%
2.67%
Stephen Mandel
Lone Pine Capital
buy
+6,567,812
+1.59%
1.59%
Current price: $151.75 266.72% AVG reported price*: $41.38
2018 Q4 (2 results)
Edgar Wachenheim III
Greenhaven Associates
-1.27%
-111,100
-0.07%
5.76%
Glenn Greenberg
Brave Warrior Advisors
+43.45%
+214,557
+0.61%
1.25%
Current price: $151.75 337.82% AVG reported price*: $34.66
2018 Q3 (2 results)
Edgar Wachenheim III
Greenhaven Associates
+0.08%
+7,400
+0.00%
5.70%
Glenn Greenberg
Brave Warrior Advisors
buy
+796,400
+1.43%
1.43%
Current price: $151.75 259.77% AVG reported price*: $42.18
2018 Q2 (1 result)
Edgar Wachenheim III
Greenhaven Associates
+6.83%
+557,592
+0.34%
5.36%
Current price: $151.75 270.12% Reported price*: $41.00
2018 Q1 (1 result)
Edgar Wachenheim III
Greenhaven Associates
-0.31%
-25,153
-0.02%
5.63%
Current price: $151.75 246.15% Reported price*: $43.84
2017 Q4 (2 results)
Ole Andreas Halvorsen
Viking Global Investors
-100.00%
-1,529,716
-0.38%
0.00%
Edgar Wachenheim III
Greenhaven Associates
-0.31%
-25,300
-0.02%
6.31%
Current price: $151.75 197.14% AVG reported price*: $51.07
2017 Q3 (2 results)
Ole Andreas Halvorsen
Viking Global Investors
-70.03%
-3,574,597
-0.92%
0.00%
Edgar Wachenheim III
Greenhaven Associates
+0.52%
+25,585
+0.03%
2.95%
Current price: $151.75 280.04% AVG reported price*: $39.93
2017 Q2 (2 results)
Ole Andreas Halvorsen
Viking Global Investors
-15.32%
-923,317
-0.21%
1.19%
Edgar Wachenheim III
Greenhaven Associates
+6.97%
+532,534
+0.28%
4.27%
Current price: $151.75 338.96% AVG reported price*: $34.57
2017 Q1 (2 results)
Edgar Wachenheim III
Greenhaven Associates
+3.24%
+201,443
+0.13%
3.39%
Ole Andreas Halvorsen
Viking Global Investors
buy
+6,027,630
+0.89%
0.89%
Current price: $151.75 355.57% AVG reported price*: $33.31
2016 Q4 (1 result)
Edgar Wachenheim III
Greenhaven Associates
+9.15%
+595,450
+0.29%
3.27%
Current price: $151.75 455.25% Reported price*: $27.33
2016 Q3 (1 result)
Edgar Wachenheim III
Greenhaven Associates
+1.67%
+111,616
+0.06%
3.91%
Current price: $151.75 402.48% Reported price*: $30.20
2016 Q2 (1 result)
Edgar Wachenheim III
Greenhaven Associates
-0.77%
-35,415
-0.03%
2.82%
Current price: $151.75 382.05% Reported price*: $31.48
2016 Q1 (1 result)
Edgar Wachenheim III
Greenhaven Associates
+6.69%
+383,448
+0.24%
3.53%
Current price: $151.75 401.98% Reported price*: $30.23
50 of 111

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.